Skip to main content

Kelyniam Global

corporate_fare Company Profile

Kelyniam Global

KLYG·OTC·Life Sciences·CIK 0001372114

Kelyniam Global is a medical device manufacturing company that produces custom prosthetics cranial implants. The company utilizes computer-aided design and computer-aided manufacturing processes to create these implants from advanced medical-grade polymers within the United States. Kelyniam Global is also involved in the development, manufacture, and distribution of custom cranial implants specifically designed for patients who require the reconstruction of cranial and facial structures. Its customer base includes surgeons, health systems, and payors. The company was incorporated in 2005 and was formerly known as Ketner Global Investments, Inc. It changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Canton, Connecticut.

Kelyniam Global (OTC:KLYG) is a publicly traded company in the Life Sciences sector. Wiseek monitors KLYG SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Kelyniam Global Reports 84% Revenue Surge, Swings to Q1 Operating Profit
Browse all tickers starting with K →
$0.145
52-week range · as of 2026-05-11 $0.053 – $0.39
Market cap
$7.27M
Volume
15K (0.3× avg)
3-mo avg 44.8K
Live data · 2026-06-25 09:17 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed KLYG - Latest Insights

KLYG
May 11, 2026, 12:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.100
Real-time Price: $0.145 info
Change: +$0.045 (+45%) info
Market Cap: $7.268M info